Does Rallies show XRTX 10-K and 10-Q filings?

Rallies organizes XRTX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is XRTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for XRTX. It does not provide personalized investment advice.

XRTX (XORTX Therapeutics Inc. Common Stock) Stock Analysis - SEC Filings

XORTX Therapeutics Inc. Common Stock (XRTX) is a publicly traded Healthcare sector company. As of May 19, 2026, XRTX trades at $2.53 with a market cap of $4.01M and a P/E ratio of 0.00. XRTX moved +0.00% today. Year to date, XRTX is -8.77%; over the trailing twelve months it is -51.40%. Its 52-week range spans $1.73 to $12.55. Rallies surfaces XRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find XRTX SEC filings?

Rallies organizes XRTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

XRTX Key Metrics

Key financial metrics for XRTX
Metric	Value
Price	$2.53
Market Cap	$4.01M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$12.55
52-Week Low	$1.73
Volume	3.33K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Latest XRTX News

XORTX Therapeutics Closes US$5M Offering with 183,577 Shares and 2.48M Warrants — May 19, 2026
XORTX Completes 1-for-5 Reverse Split to Regain Nasdaq Compliance — Apr 21, 2026
XORTX Closes $3M Purchase of VB4-P5 Kidney Anti-Fibrotic Program — Apr 13, 2026
XRTX to Consolidate Shares 1-for-5 Effective April 6 After Exchange Approvals — Apr 1, 2026
XORTX Therapeutics Plans 1-for-5 Reverse Stock Split and Highlights Three Clinical Assets — Mar 30, 2026

XRTX Analyst Consensus

XRTX analyst coverage data. Average price target: $0.00.

Common questions about XRTX

Where can I find XRTX SEC filings?: Rallies organizes XRTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show XRTX 10-K and 10-Q filings?: Rallies organizes XRTX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is XRTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for XRTX. It does not provide personalized investment advice.